MYRIAD GENETICS, INC. Contract with Customer, Performance Obligation Satisfied in Previous Period
MYRIAD GENETICS, INC. (MYGN) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of -$11.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Revenue from Contract with Customer
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2026-07-31
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2026-06-30 was -$11.00M.
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2026-03-31 was $0.00.
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-06-30 was $0.00.
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for the quarter ending 2024-03-31 was $3.00M.
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2024 was $21.50M, a 198.61% increase from fiscal 2023.
- MYRIAD GENETICS, INC. contract with customer, performance obligation satisfied in previous period for fiscal 2023 was $7.20M.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|
| 2026-06-30 | -$11.00M 10-Q · filed 2026-07-31 | -$8.00M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-31 | $0.00 10-Q · filed 2026-07-31 | |
| 2024-12-31 | $21.50M 10-K · filed 2026-02-24 | ||
| 2024-03-31 | $3.00M 10-K · filed 2026-02-24 | ||
| 2023-12-31 | $7.20M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |